Resource Centre
Discover a wealth of knowledge and insights from the experts at StarFish Medical. Our Resource Centre offers product development tips, reviews of new and cutting-edge technologies, and in-depth articles on regulatory updates and compliance in medical device development.
-
In medical device development, we deal with complex projects that span multiple disciplines, timelines, and regulatory gates. It’s a constant balance between moving fast enough to innovate, but slow enough to stay compliant.
-
Ariana and Mark walk through FDA-approved options and explain how to select the right one for your product. From metals to plastics and electronics, not all devices can handle the same process.
-
In this episode of MedDevice by Design, Ariana and Mark dive into the biomechanics and materials science behind osseointegration for implants.
-
Ariana and Mark explore how accommodative intraocular lens technology may one day restore natural vision for people who require cataract surgery or suffer from presbyopia. As Mark shares, traditional bifocals are not ideal, and new lens solutions may offer better outcomes.
-
Many clients now request their devices to look and feel like Apple products. But achieving that level of simplicity and elegance is not as easy as it seems.
-
You have a great MedTech innovation idea and are trying to decide whether to build a team to commercialize a medical device…
-
We explore the world of brain-computer interfaces (BCIs) and the challenges of capturing thought into action. Mark Drlik and Ariana Wilson walk through how these systems translate brain activity into control signals for devices—without needing surgical implants.
-
The impact of shear stress is critical to effectively design medical devices that handle biological fluids such as proteins or cell culture media. For example, non-physiological shear stress (NPSS) on blood is a key factor because hemolysis (cell rupture) could occur due to accumulated stress.
-
The costs of early-stage medical device development in North America and Europe continue to rise. Increasing technical complexity and the compounding costs of nonclinical and clinical evaluations are driving this trend.
